Intel stock extends gains after report of possible U.S. government stake
LARGO, Fla. - Medical technology company CONMED Corporation (NYSE:CNMD), with a market capitalization of $1.65 billion and a "GOOD" financial health rating according to InvestingPro, announced Thursday that its Board of Directors has declared a quarterly cash dividend of $0.20 per share. The dividend, declared on August 7, will be payable on October 3, 2025, to shareholders of record as of September 15, 2025.
CONMED, which specializes in providing devices and equipment for surgical procedures, maintains its regular quarterly dividend distribution to shareholders, having sustained dividend payments for 14 consecutive years with a current yield of 1.5%. The company’s products are used by healthcare professionals across multiple specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology.
The dividend announcement comes as part of the company’s ongoing capital allocation strategy. CONMED has consistently provided returns to shareholders through its dividend program.
The information in this article is based on a press release statement issued by CONMED Corporation.
In other recent news, CONMED Corporation reported its financial results for the second quarter of 2025, beating both earnings and revenue expectations. The company posted an adjusted earnings per share of $1.15, surpassing the anticipated $1.12. Revenue for the quarter came in at $342.3 million, slightly higher than the forecasted $338.4 million. These results represent a 2.68% surprise in earnings performance. Despite the positive financial outcomes, the company’s stock experienced a slight decline in after-hours trading. This minor drop brought the closing price to $50.29. The stock’s performance remains close to the lower end of its 52-week range. These developments are part of the recent updates surrounding CONMED Corporation.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.